Sci-Tech Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Europe.

Press releases published on October 5, 2026

Oct. 5, 2026

CTW to Announce Fiscal Year 2026 Financial Results on October 15 and Host Earnings Webinar on October 16

Indeterminate GlobeNewswire

Oct. 5, 2026

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

Indeterminate GlobeNewswire

Oct. 5, 2026

Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 5, 2026

Leonardo DRS Completes Training and Delivery of INOD Block III Thermal Weapon Sights for the Australian Army

Indeterminate GlobeNewswire

Oct. 5, 2026

iCell Gene Therapeutics Announces Upcoming Conference Presentations

Indeterminate GlobeNewswire

Oct. 5, 2026

ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

Indeterminate GlobeNewswire

Oct. 5, 2026

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

Indeterminate GlobeNewswire

Oct. 5, 2026

Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 5, 2026

BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day

Indeterminate GlobeNewswire

Oct. 5, 2026

DigitalXForce Named a Leader in IDC MarketScape for Third-Party Risk Management

Indeterminate EIN Presswire

Oct. 5, 2026

WIN Semiconductors Welcomes SawStreet LLC to the WIN ALLIANCE Partner Program

Indeterminate EIN Presswire

Oct. 5, 2026

SGS advances Digital Trust strategy with Prescient Security acquisition

Indeterminate EIN Presswire

Oct. 5, 2026

Big Bear Gold Corp. Announces Change of Transfer Agent to Olympia Trust Company

Indeterminate GlobeNewswire

Oct. 5, 2026

Environmental Toxins and Brain Health: Experts Explore Cognitive Decline, Alzheimer’s Research and Therapeutic Plasma Exchange

Indeterminate GlobeNewswire

Oct. 5, 2026

FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms

Indeterminate GlobeNewswire

Oct. 5, 2026

Financial Close Automation Enters a New Phase: 67% of UK CFOs Prioritise Account Reliability Over Speed, Sixthfin Research Finds

Indeterminate GlobeNewswire

Oct. 5, 2026

The DevEx(odus): AI adoption targets are driving ‘performative’ use, anxiety and an impending exodus amongst developers

Indeterminate EIN Presswire

Oct. 5, 2026

Telos Secures $13.5 Million Contract to Continue Support of Air Force Intelligence Community Cyber Operations

Indeterminate GlobeNewswire

Oct. 5, 2026

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Indeterminate GlobeNewswire

Oct. 5, 2026

Free Browser Game Fibre Tycoon Lets Anyone Build Britain's Full Fibre Network

Indeterminate EIN Presswire